Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 4.3% – What’s Next?

by · The Markets Daily

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report)’s share price dropped 4.3% during trading on Wednesday . The company traded as low as $22.25 and last traded at $22.7725. 73,963 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 253,948 shares. The stock had previously closed at $23.79.

Wall Street Analysts Forecast Growth

Separately, Zacks Research cut Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Get Our Latest Analysis on DSNKY

Daiichi Sankyo Stock Performance

The company has a market cap of $43.44 billion and a P/E ratio of 21.63. The business has a 50 day moving average price of $24.36 and a two-hundred day moving average price of $24.37. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.60 and a current ratio of 2.31.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Recommended Stories